Literature DB >> 8313244

Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis.

A Eisen1, C Krieger.   

Abstract

In recognition of the 100th anniversary of Charcot's death we have reviewed possible pathogenic mechanisms in amyotrophic lateral sclerosis (ALS). Advances in the last 5 years in molecular biology and genetics have identified mutations in the cytosolic dismutase (SOD1) gene in some patients with familial ALS raising the possibility that oxidative stress may be involved in the pathogenesis. An excitotoxic pathogenesis has been implicated based on elevated plasma and CSF levels of amino acids and altered contents of amino acids in the nervous system of ALS patients and changes in the number of excitatory amino acid receptors. ALS sera containing antibodies to L-type calcium channels and the development of immune mediated lower and upper and lower motor neuron models have revitalized research efforts focusing on an immune basis for ALS. Other pathogenic mechanisms which have been the subject of recent research include elemental toxicity, apoptosis and programmed cell death and possibly a deficiency or abnormality in growth factors. Pathogenic processes for ALS must account for an increasing incidence of ALS, male preponderance, and the selective vulnerability of the cortico-motoneuronal system.

Entities:  

Mesh:

Year:  1993        PMID: 8313244

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  4 in total

Review 1.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 2.  Amyotrophic lateral sclerosis: is excitotoxicity the key?

Authors:  G Krueger
Journal:  CMAJ       Date:  1994-08-15       Impact factor: 8.262

Review 3.  The relationship between amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  George M Ringholz; Scott R Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

4.  The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment.

Authors:  Pietro Cipresso; Laura Carelli; Federica Solca; Daniela Meazzi; Paolo Meriggi; Barbara Poletti; Dorothée Lulé; Albert C Ludolph; Vincenzo Silani; Giuseppe Riva
Journal:  Brain Behav       Date:  2012-07       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.